Status:
COMPLETED
Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist
Lead Sponsor:
University Hospital Schleswig-Holstein
Conditions:
Ovarian Hyperstimulation Syndrome
Eligibility:
All Genders
18-39 years
Brief Summary
The aim of the study is to explore the concept of GnRH-agonist triggering in combination with elective cryopreservation of all 2PN oocytes at larger scale in a pragmatic clinical setting. The question...
Eligibility Criteria
Inclusion
- Indication for IVF with ICSI
- Age \< 40 years
- \< 4 failed previous IVF attempts with embryo transfer
- ovarian stimulation with GnRH-antagonist and gonadotrophins
- \>20 follicles \>11 mm in mean diameter or E2 \>4500 pg/ml on the day , on which it was planned to administer hCG
- willing to participate and able to consent
- patient has not previously received GnRH-agonist as a trigger of final oocyte maturation
Exclusion
- None
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT00835523
Start Date
May 1 2008
End Date
July 1 2010
Last Update
June 14 2012
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
IVF-Augsburg
Augsburg, Germany, 86150
2
Deutsche Klinik Bad Münder
Bad Münder am Deister, Germany, 31848
3
Department of Obestrics and Gynecology, University Bonn
Bonn, Germany, 53127
4
Department of Obestrics and Gynecology, University Cologne
Cologne, Germany, 50931